Furthermore, (likely) pathogenic mutations were detected in BRAF, HNF1A, SMAD4, MUTYH, FBXW7 and TSC2. Pathogenic and likely pathogenic mutations were mainly consistent in tumours and metastases. This evidence concerns the gene MUTYH and neoplasm.